Loading…

Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies

To test the diagnostic performance of BNP and NT-ProBNP in children with different hemodynamic dysfunctions. Seventy children who underwent echocardiography and were classified into left and right ventricle volume and pressure overload (LVvO, LVpO, RVvO, and RVpO, respectively) and biventricular vol...

Full description

Saved in:
Bibliographic Details
Published in:Clinical biochemistry 2010-11, Vol.43 (16), p.1278-1281
Main Authors: Şahin, Murat, Portakal, Oytun, Karagöz, Tevfik, Hasçelik, Gülşen, Özkutlu, Süheyla
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To test the diagnostic performance of BNP and NT-ProBNP in children with different hemodynamic dysfunctions. Seventy children who underwent echocardiography and were classified into left and right ventricle volume and pressure overload (LVvO, LVpO, RVvO, and RVpO, respectively) and biventricular volume overload (BVvO) were enrolled. BNP and NT-ProBNP levels in all groups were higher than those in the control group (p < 0.001, p < 0.001). The increase in peptide levels was strongly correlated with the severity of heart failure (p < 0.001, p < 0.001). There was no significant difference in peptide levels in-between LVvO, LVpO, RVvO, RVpO and BVvO groups. Both measurements were significantly correlated (r = 0.76, p < 0.001) with each other. NT-ProBNP showed a high sensitivity, whereas BNP showed a high specificity and accuracy. AUCs in ROC-curve were 0.97 for BNP and 0.96 for NT-ProBNP. NT-ProBNP may be used in screening of risk groups for cardiac failure because of its' higher sensitivity, but BNP may be specifically used in monitoring patients with heart failure.
ISSN:0009-9120
1873-2933
DOI:10.1016/j.clinbiochem.2010.08.002